RetinalGenix Technologies (RetinalGenix Technologies) Additional Paid-In Capital : $11.73 Mil(As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Additional Paid-In Capital?

RetinalGenix Technologies's quarterly additional paid-in capital increased from Sep. 2023 ($9.48 Mil) to Dec. 2023 ($9.70 Mil) and increased from Dec. 2023 ($9.70 Mil) to Mar. 2024 ($11.73 Mil).

RetinalGenix Technologies's annual additional paid-in capital increased from Dec. 2021 ($4.64 Mil) to Dec. 2022 ($7.95 Mil) and increased from Dec. 2022 ($7.95 Mil) to Dec. 2023 ($9.70 Mil).

RetinalGenix Technologies Additional Paid-In Capital Historical Data

The historical data trend for RetinalGenix Technologies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Additional Paid-In Capital Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

2.84

4.64

7.95

9.70

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial										8.03	8.10	9.48	9.70	11.73

RetinalGenix Technologies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

RetinalGenix Technologies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.